Novel viral vector vaccines for tropical infections by Rampling, T

International biological reference preparations for emerging infectious diseases: vital tools in epidemic preparedness by Rampling, T, Page, M, Horby, P

International biological reference preparations for epidemic infectious diseases by Rampling, T, Page, M, Horby, P

Achieving biodiversity net gain by addressing governance gaps underpinning ecological compensation policies by Rampling, E, Zu Ermgassen, S, Hawkins, I, Bull, J

Activation-induced markers detect vaccine-specific CD4⁺ T cell responses not measured by assays conventionally used in clinical trials by Bowyer, G, Rampling, T, Powlson, J, Morter, R, Wright, D, Hill, A, Ewer, K

Biochemical investigation of human tumours in vivo with phosphorus-31 magnetic resonance spectroscopy. by Oberhaensli, R, Hilton-Jones, D, Bore, P, Hands, L, Rampling, R, Radda, G

CXCR3+ T follicular helper cells induced by co-administration of RTS,S/AS01B and viral vectored vaccines are associated with reduced immunogenicity and efficacy against Malaria by Ewer (nee Russell), K, Bowyer, G, Grobbelaar, A, Rampling, T, Venkatraman, N, Morelle, D, Ballou, R, Hill, A

Detection of vaccine-induced antibodies to Ebola virus in oral fluid by Lambe, T, Rampling, T, Samuel, D, Bowyer, G, Ewer, K, Venkatraman, N, Edmans, M, Dicks, S, Hill, A, Tedder, R, Gilbert, S

Characterisation of antigenic MHC Class I-restricted T cell epitopes in the glycoprotein of Ebolavirus by Powlson, J, Wright, D, Zeltina, A, Giza, M, Nielsen, M, Rampling, T, Venkatraman, N, Bowden, T, Hill, A, Ewer, K

Probability of transmission of malaria from mosquito to human is regulated by mosquito parasite density in naïve and vaccinated hosts by Churcher, TS, Sinden, RE, Edwards, NJ, Poulton, ID, Rampling, TW, Brock, PM, Griffin, JT, Upton, LM, Zakutansky, SE, Sala, KA, Angrisano, F, Hill, AVS, Blagborough, AM

Safety and immunogenicity of the heterologous prime-boost ebolavirus vaccine regimen CHAD3-EBO Z and MVA-BN (R) FILO in healthy UK adults by Rampling, T, Ewer, K, Bowyer, G, Wright, D, Venkatraman, N, Payne, R, Nicosia, A, Sullivan, N, Graham, B, Pollard, A, Draper, S, Ballou, R, Lawrie, A, Gilbert, S, Hill, A

Establishment of a clinical helpline for mpox: comparison of the 2022 and 2024 experience in the UK by Dr Helen Callaby, Dr Jane Osborne, Dr Catherine F Houlihan, Dr Tommy Rampling, Dr Amy Belfield, Dr Clare Warrell, Dr Christina Petridou, Dr Matthew Donati, Dr Nicola C Gordon

Get full text

Safety and high level efficacy of the combination malaria vaccine regimen of RTS,S/AS01B with ChAd-MVA vectored vaccines expressing ME-TRAP by Rampling, T, Ewer, K, Bowyer, G, Bliss, C, Edwards, N, Wright, D, Payne, R, Venkatraman, N, Snudden, C, Poulton, I, Roberts, R, Sinden, R, Gerry, S, Lawrie, A, Gilbert, S, Hill, A

Durability of immune responses induced by three leading candidate ebola vaccine regimes; rVSV ZEBOV, ChAd3 EBO Z-MVA BN-Filo and AdHu26.ZEBOV-MVA BN Filo by Ewer, K, Smith, C, Sarkar, E, Bowyer, G, Rampling, T, Mair, C, Bellamy, D, Sabir, S, Davies, C, Venkatraman, N, Conway-Jones, R, Campbell, D, Boyer, C, Hill, A, Thomson, E, Snape, M

Monkeypox virus isolation from longitudinal samples in 11 hospitalised patients by Callaby, H, Olver, J, Emery, K, Richards, KS, Killip, M, Groves, N, Beadsworth, MBJ, Price, DA, Cooke, GS, Collini, P, Cole, J, Dunning, J, Semple, MG, Baillie, JK, ISARIC4C Investigators, Rampling, T, Houlihan, CF

Monkeypox virus (MPXV) isolation from longitudinal samples of 11 patients to infer risk of onwards transmission by Dr Helen Callaby, Dr Janie Olver, Ms Kirsty Emery, Dr Kevin Richards, Dr Marian Killip, Dr Natalie Groves, Dr Jake Dunning, Professor Malcolm G Semple, Professor J Kenneth Baillie, Dr Tommy Rampling, Dr Catherine F Houlihan

Get full text

Stem cell transplantation for tetratricopeptide repeat domain 7A deficiency: long-term follow-up by Kammermeier, J, Lucchini, G, Pai, S, Worth, A, Rampling, D, Amrolia, P, Silva, J, Chiesa, R, Rao, K, Noble-Jamieson, G, Gasparetto, M, Ellershaw, D, Uhlig, H, Sebire, N, Elawad, M, Notarangelo, L, Shah, N, Veys, P

Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trial. by Hodgson, S, Choudhary, P, Elias, S, Milne, K, Rampling, T, Biswas, S, Poulton, I, Miura, K, Douglas, A, Alanine, D, Illingworth, J, de Cassan, S, Zhu, D, Nicosia, A, Long, C, Moyle, S, Berrie, E, Lawrie, A, Wu, Y, Ellis, R, Hill, A, Draper, S

Clinical characteristics of patients admitted to pneumonic plague treatment centers during the 2017 madagascar pneumonic plague outbreak: A prospective observational study by Salam, A, Raberahona, M, Rajerison, M, Andriantsalama, P, Funk, A, Castle, L, Andrianarintsiferantsoa, F, Rakotomahefa, M, Rakotoarivelo, R, Rabezanahary, H, Bertherat, E, Renaud, B, Rojek, A, Rampling, T, Denis, E, Heraud, J-M, Randrianirina, F, Baril, L, Fontanet, A, Horby, P, Randria, M, Randremanana, R

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children by Tiono, AB, Nebie, I, Anagnostou, N, Coulibaly, AS, Bowyer, G, Lam, E, Bougouma, EC, Ouedraogo, A, Yaro, JBB, Barry, A, Roberts, R, Rampling, T, Bliss, C, Hodgson, S, Lawrie, A, Ouedraogo, A, Imoukhuede, EB, Ewer, KJ, Viebig, NK, Diarra, A, Leroy, O, Bejon, P, Hill, A, Sirima, SB